Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02306291
Title Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlycoMimetics Incorporated
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | IRL | AUS


No variant requirements are available.